Clinical trial

5-HTP and Creatine for Depression R33 Phase

NCT05895747

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-09-28

PhasePHASE2

Study timeline

Study start (actual)2023-09-28Date precision: day

Registry last updated2026-08-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Low Dose 5-hydroxytryptophanDRUG

High Dose 5-hydroxytryptophanDRUG

Low Dose Creatine MonohydrateDRUG

High Dose Creatine MonohydrateDRUG

Sponsors & collaborators

University of Utahlead sponsor

Mapped research locations

Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05895747 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.